Garcia Márcia Fátima Faraldo Martinez, Bravin Ariane Moyses, Garcia Paula Dalsoglio, Contti Mariana Moraes, Nga Hong Si, Takase Henrique Mochida, de Andrade Luis Gustavo Modelli
Department of Internal Medicine - UNESP, Univ Estadual Paulista, Rubião Jr, S/N, Botucatu, SP, 18.618-970, Brazil.
Int Urol Nephrol. 2015 Nov;47(11):1899-905. doi: 10.1007/s11255-015-1104-z. Epub 2015 Sep 16.
Solid-organ transplant recipients present a high rate of non-adherence to drug treatment. Few interventional studies have included approaches aimed at increasing adherence. The objective of this study was to evaluate the impact of an educational and behavioral strategy on treatment adherence of kidney transplant recipients.
In a randomized prospective study, incident renal transplant patients (n = 111) were divided into two groups: control group (received usual transplant patient education) and treatment group (usual transplant patient education plus ten additional weekly 30-min education/counseling sessions about immunosuppressive drugs and behavioral changes). Treatment adherence was assessed using ITAS adherence questionnaire after 3 months. Renal function at 3, 6, and 12 months, and the incidence of transplant rejection were evaluated.
The non-adherence rates were 46.4 and 14.5 % in the control and treatment groups (p = 0.001), respectively. The relative risk for non-adherence was 2.59 times (CI 1.38-4.88) higher in the control group. Multivariate analysis demonstrated a 5.84 times (CI 1.8-18.8, p = 0.003) higher risk of non-adherence in the control group. There were no differences in renal function and rejection rates between groups.
A behavioral and educational strategy addressing the patient's perceptions and knowledge about the anti-rejection drugs significantly improved the short-term adherence to immunosuppressive therapy.
实体器官移植受者药物治疗依从性较差。很少有干预性研究采用旨在提高依从性的方法。本研究的目的是评估一种教育和行为策略对肾移植受者治疗依从性的影响。
在一项随机前瞻性研究中,将新发肾移植患者(n = 111)分为两组:对照组(接受常规移植患者教育)和治疗组(常规移植患者教育加上每周额外进行十次30分钟关于免疫抑制药物和行为改变的教育/咨询课程)。3个月后使用ITAS依从性问卷评估治疗依从性。评估3、6和12个月时的肾功能以及移植排斥反应的发生率。
对照组和治疗组的不依从率分别为46.4%和14.5%(p = 0.001)。对照组不依从的相对风险高2.59倍(CI 1.38 - 4.88)。多变量分析表明对照组不依从风险高5.84倍(CI 1.8 - 18.8,p = 0.003)。两组之间的肾功能和排斥率没有差异。
一种针对患者对抗排斥药物的认知和知识的行为和教育策略显著提高了免疫抑制治疗的短期依从性。